• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

SISRAM MED(01696.HK)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Aug20
SISRAM MED released FY2025 Q1 earnings on August 20 (BJT), actual revenue HKD 643.65 M, actual EPS HKD 0.0532
15:00
ReAve Medical Technology's Revenue Down 1.9% in H1 2025 Earnings Report
13:35
SISRAM MED released FY2025 Q2 earnings on August 20 After-Market (BJT), actual revenue HKD 649.49 M, actual EPS HKD 0.0537
11:00
SISRAM MED released FY2025 Semi-Annual earnings on August 20 After-Market (BJT), actual revenue HKD 1.293 B, actual EPS HKD 0.107
11:00
Aug12
SISRAM MED to Release FY2025 Semi-Annual Earnings on August 20, 2025 (BJT)
00:25
Jul22
Revalo Medical Technology Launches AI-based Skincare Product
10:48

Schedules & Filings

Schedules
Filings
Sep9
Distribution Plan(CST)

Cash dividend 0.126 HKD

Aug27
Distribution Plan(CST)

Cash dividend 0.126 HKD

Aug26
Distribution Plan(CST)

Cash dividend 0.126 HKD

View More

DolphinResearch

Global Tech Blitz: Nvidia Invests in Synopsys, Apple AI Shakeup, Alibaba Updates AI Model | Today's Important News Recap
12-02 16:17
Intel (Minutes): 18A is expected to contribute to profits by the end of 2026
10-24 11:27

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
00312
0.087
+81.25%
+0.039
01045
3.710
+33.45%
+0.930
02478
1.670
+30.47%
+0.390
08106
0.400
+29.03%
+0.090
02349
0.083
+27.69%
+0.018
00498
0.153
+27.50%
+0.033
08460
2.860
+26.55%
+0.600
01271
1.100
+26.44%
+0.230
08311
0.099
+25.32%
+0.020
01559
0.086
+22.86%
+0.016
View More